Education
About Us
Working with TipRanks
Follow Us
Intra-Cellular Therapies (ITCI)
:ITCI
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 680.85M | $ 464.37M | $ 249.13M | $ 81.71M | $ 22.53M |
| Gross Profit | $ 623.89M | $ 430.63M | $ 228.69M | $ 73.67M | $ 20.64M |
| Operating Income | $ -116.72M | $ -159.38M | $ -263.63M | $ -285.69M | $ -231.23M |
| EBITDA | $ -116.72M | $ -158.85M | $ -262.97M | $ -285.15M | $ -230.70M |
| Net Income | $ -74.68M | $ -139.67M | $ -256.26M | $ -284.13M | $ -227.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.00B | $ 497.94M | $ 591.90M | $ 412.33M | $ 657.45M |
| Total Assets | $ 1.37B | $ 728.29M | $ 754.78M | $ 489.92M | $ 717.31M |
| Total Debt | $ 16.98M | $ 16.94M | $ 20.04M | $ 25.41M | $ 29.14M |
| Net Debt | $ -289.97M | $ -130.83M | $ -128.57M | $ -66.96M | $ -30.90M |
| Total Liabilities | $ 218.45M | $ 136.87M | $ 98.71M | $ 72.03M | $ 60.45M |
| Stockholders' Equity | $ 1.15B | $ 591.42M | $ 656.07M | $ 417.89M | $ 656.86M |
| Cash Flow | |||||
| Free Cash Flow | $ -73.50M | $ -124.47M | $ -270.96M | $ -259.87M | $ -230.34M |
| Operating Cash Flow | $ -73.18M | $ -124.20M | $ -270.19M | $ -259.54M | $ -230.07M |
| Investing Cash Flow | $ -335.15M | $ 105.54M | $ -128.37M | $ 280.34M | $ -480.30M |
| Financing Cash Flow | $ 567.51M | $ 17.81M | $ 455.16M | $ 11.52M | $ 664.18M |